Pure Global AI
ANVISA registration 81546350095Active

PRÉ-ALBUMINA (TRANSTIRETINA)

ANVISA Registration Number: 81546350095Nanosens LtdaDIAGAM S.A.Risk Class II
Verified
Device names
Technical name
PRÉ-ALBUMINA (TRANSTIRETINA)
View exact technical-name matches →
Commercial name
Pré-albumina
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
81546350095
Process Number
25351134277202623
CNPJ
25407581000101
Company information
Registration Holder
Nanosens Ltda
Manufacturer
DIAGAM S.A.
Manufacturing Country
Belgium
PT: BÉLGICA
Dates and status
Publication Date
Aug 24, 2026
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for PRÉ-ALBUMINA (TRANSTIRETINA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81546350095 and manufactured by DIAGAM S.A.. The registration is held by Nanosens Ltda with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.